Alphatec price to free cash flow ATEC

Market value divided by free cash flow over the last twelve months, since 2016.

Today, Oct 23, 2026: n/m; a sliver of free cash flow
Last meaningful: 207×; Jul 2026
Peer median: 28.1×

Alphatec's price to free cash flow is not a meaningful number today: a multiple this high rests on a sliver of free cash flow.

It was last meaningful in Jul 2026, at 207×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	207×	164×	209×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	n/m a value too high to mean anything
2016	100×	61.9×	247×

Against its peers

Companies in Medical - Instruments & Supplies nearest Alphatec's size, closest first, today.

Company	Price to free cash flow
ATECAlphatec	n/m
LMATLemaitre Vascular	26.2×
EYENational Vision	30.1×
INSPInspire Medical Systems	17.6×
UFPTUFP Technologies	n/m
CDRECadre	16.4×
BVSBioventus	13.3×
STAAStaar Surgical	n/m
IRMDIradimed	43.7×
ATRCAtriCure	56.5×
WRBYWarby Parker	147×
Peer median	28.1×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Alphatec

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.